Genen­tech is the lat­est drug­mak­er to sue the fed­er­al gov­ern­ment over STD clin­ics it says are wrong­ful­ly re­ceiv­ing dis­counts through the fed­er­al 340B pro­gram. … ...

Daniel Vitt, CEO, Immunic Therapeutics, discusses promising results from the Phase Ib trial of IMU-856 in celiac disease. PE: The phase Ib trial demonstrated improvements in histology, symptoms, ...

Sales in Roche’s pharmaceutical division grew 8% to CHF 46.2bn ($50.9bn). Credit: hapabapa via Getty Images. Roche has reported a 7% increase in full-year 2024 sales at constant exchange rates (CER), ...

Rentschler’s CEO said the cell and gene therapy market demand hat not met the company’s expectations. Image credit: Shutterstock/ REDPIXEL.PL. CDMO Rentschler Biopharma is signalling its intent to cut ...

This study aims to address the challenges of applying rotation INS technology within MEMS-IMU/DVL systems, potentially enabling them to replace FOG systems—something that non-rotating MEMS-IMUs cannot ...

'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...